These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7030587)

  • 61. The animal rule and emerging infections: the role of clinical pharmacology in determining an effective dose.
    Bergman KL
    Clin Pharmacol Ther; 2009 Sep; 86(3):328-31. PubMed ID: 19571806
    [No Abstract]   [Full Text] [Related]  

  • 62. Prophylactic antibiotics in abdominal hysterectomy.
    Tanos V; Rojansky N
    J Am Coll Surg; 1994 Nov; 179(5):593-600. PubMed ID: 7952465
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Pharmacokinetic interference between furosemide and cephalosporins].
    Iakovlev VP; Klimova VS; Em SV; Rudzit EA
    Antibiotiki; 1981 Apr; 26(4):287-90. PubMed ID: 7235669
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Influence of exogenous thiols on inorganic mercury-induced injury in renal proximal and distal tubular cells from normal and uninephrectomized rats.
    Lash LH; Putt DA; Zalups RK
    J Pharmacol Exp Ther; 1999 Nov; 291(2):492-502. PubMed ID: 10525063
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cephalosporin nephrotoxicity.
    Hinrichs JH
    Lancet; 1979 Jun; 1(8131):1408. PubMed ID: 87868
    [No Abstract]   [Full Text] [Related]  

  • 66. Cephaloridine versus cephalothin: relation of the kidney to blood level differences after parenteral administration.
    Tuano SB; Brodie JL; Kirby WM
    Antimicrob Agents Chemother (Bethesda); 1966; 6():101-6. PubMed ID: 5985234
    [No Abstract]   [Full Text] [Related]  

  • 67. Effect of intravenous contrast media on proximal and distal tubular hydrostatic pressure in the rat kidney.
    Ueda J; Nygren A; Hansell P; Ulfendahl HR
    Acta Radiol; 1993 Jan; 34(1):83-7. PubMed ID: 8427755
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Declining renal function associated with administration of cephalothin.
    Pickering MJ; Spooner GR; de Quesada A; Cade JR
    South Med J; 1970 Apr; 63(4):426-8. PubMed ID: 5437593
    [No Abstract]   [Full Text] [Related]  

  • 69. Laboratory and clinical evaluation of cephaloridine in 78 patients.
    Cohen PG; Romansky MJ; Johnson AC
    Antimicrob Agents Chemother (Bethesda); 1965; 5():894-900. PubMed ID: 5327533
    [No Abstract]   [Full Text] [Related]  

  • 70. The targeting of anionized polyvinylpyrrolidone to the renal system.
    Kodaira H; Tsutsumi Y; Yoshioka Y; Kamada H; Kaneda Y; Yamamoto Y; Tsunoda S; Okamoto T; Mukai Y; Shibata H; Nakagawa S; Mayumi T
    Biomaterials; 2004 Aug; 25(18):4309-15. PubMed ID: 15046921
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical evaluation of cephaloridine.
    Dennis M; Rasch JR; Hastings HK
    Antimicrob Agents Chemother (Bethesda); 1965; 5():724-7. PubMed ID: 5327529
    [No Abstract]   [Full Text] [Related]  

  • 72. Targeted prevention of renal accumulation and toxicity of gentamicin by aminoglycoside binding receptor antagonists.
    Watanabe A; Nagai J; Adachi Y; Katsube T; Kitahara Y; Murakami T; Takano M
    J Control Release; 2004 Mar; 95(3):423-33. PubMed ID: 15023454
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ultrastructure of kidney renal proximal convoluted tubules of experimental animals after Cladribine (2-CdA) administration.
    Lis-Sochocka M; Lańcut M; Czerny K
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):157-62. PubMed ID: 16145972
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Transcriptomic analysis of nephrotoxicity induced by cephaloridine, a representative cephalosporin antibiotic.
    Rokushima M; Fujisawa K; Furukawa N; Itoh F; Yanagimoto T; Fukushima R; Araki A; Okada M; Torii M; Kato I; Ishizaki J; Omi K
    Chem Res Toxicol; 2008 Jun; 21(6):1186-96. PubMed ID: 18500788
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [The application of modern pharmacology to medical practice].
    Scholtholt J
    Fortschr Med; 1980 Aug; 98(30-31):1139-43. PubMed ID: 7419157
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Clinical experiences with cephaloridin].
    Foord RD; Snell ES
    Praxis; 1966 Sep; 55(35):978-85. PubMed ID: 5953221
    [No Abstract]   [Full Text] [Related]  

  • 77. [Aminoglycosides, risk factors and neonatal kidney].
    Khoory BJ; Fanos V; Dall'Agnola A; Cataldi L
    Pediatr Med Chir; 1996; 18(5):495-9. PubMed ID: 9053889
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Tubular interstitial disorders in the nephrotoxic action of antibiotics].
    Potapova AV; Dzgoeva FU; Kutyrina IM; Zozulia OV; Okunev DIu; Milovanov IuS
    Urol Nefrol (Mosk); 1995; (3):11-4. PubMed ID: 7618213
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The localisation of cephaloridine and nitrofurantoin in the kidney.
    Currie GA; Little PJ; McDonald SJ
    Nephron; 1966; 3(5):282-8. PubMed ID: 5965069
    [No Abstract]   [Full Text] [Related]  

  • 80. Cephaloridine therapy as related to renal function.
    Kabins SA; Cohen S
    Antimicrob Agents Chemother (Bethesda); 1965; 5():922-32. PubMed ID: 5883518
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.